Celyad Oncology S.A. (CYAD) - Financials, balance sheet (quarterly)

0.37000000 EUR

0.02

5.71%

Last update Jul 11, 5:35 PM CEST

Market closed

Day range

0.37000000

0.34200001

0.37300000

Previous close

0.34999999

Open

0.34200001

Access this stock data via API

Celyad Oncology S.A.

0.37

0.02

5.71%

Financials

Balance sheet

Fiscal date	Jun 2023	Jun 2022	Mar 2022	Dec 2021
Total assets	12.2M	63.1M	69.2M	79.9M
Current assets	7.7M	19.4M	26.1M	34.3M
Cash	—	14.4M	—	30.0M
Cash equivalents	—	—	—	—
Cash and cash equivalents	5.0M	14.4M	20.5M	30.0M
Other short term investments	0	0	0	0
Accounts receivable	879K	466K	933K	203K
Other receivables	1.2M	2.9M	2.4M	1.6M
Inventory	—	—	—	—
Prepaid assets	—	1.3M	—	1.9M
Restricted cash	—	—	—	—
Assets held for sale	0	—	—	0
Hedging assets	—	—	—	—
Other current assets	622K	—	2.2M	—
Non current assets	4.5M	43.8M	43.1M	45.7M
Properties	—	—	—	6.8M
Land and improvements	—	—	—	—
Machinery furniture equipment	—	—	—	250K
Construction in progress	—	—	—	—
Leases	—	—	—	4.1M
Accumulated depreciation	—	—	—	-7.8M
Goodwill	645K	37.5M	36.0M	37.1M
Investment properties	—	—	—	—
Financial assets	—	—	—	—
Intangible assets	—	35.7M	—	35.3M
Investments and advances	—	—	—	—
Other non current assets	3.0M	4.3M	4.2M	6.0M
Total liabilities	11.2M	32.5M	32.7M	36.3M
Current liabilities	6.1M	11.4M	10.1M	13.8M
Accounts payable	3.4M	6.0M	5.5M	6.6M
Accrued expenses	—	2.1M	—	1.8M
Short term debt	185K	783K	841K	902K
Deferred revenue	763K	1.5M	343K	1.5M
Tax payable	—	—	—	—
Pensions	—	262K	—	332K
Other current liabilities	1.7M	392K	3.4M	2.3M
Non current liabilities	5.1M	21.1M	22.6M	22.5M
Long term provisions	—	—	—	—
Long term debt	351K	1.4M	1.6M	1.7M
Provision for risks and charges	0	13.6M	14.7M	14.7M
Deferred liabilities	—	—	—	—
Derivative product liabilities	—	—	—	—
Other non current liabilities	217K	178K	167K	164K
Shareholders equity
Common stock	78.6M	78.6M	78.6M	78.6M
Retained earnings	-353.7M	-323.1M	-316.6M	-309.0M
Other shareholders equity	269.8M	268.8M	268.2M	267.7M
Total shareholders equity	1.0M	30.7M	36.5M	43.6M
Additional paid in capital	6.3M	6.3M	6.3M	6.3M
Treasury stock	—	—	—	—
Minority interest	—	—	—	—